DEFTA Partners is a venture capital firm in San Francisco that focuses on the information technology and healthcare sectors. Founded in 1984 in San Francisco, California, the firm invests in early stage venture, late stage venture, and seed stages. This firm usually invests in series A and series B rounds. The notable investment portfolio of DEFTA Partners includes Cloudfiling, Fortinet, bracNet, Abilitech Medical, Aivick, etc.
As of January 2020, DEFTA Partners has made 56 investments and 25 exits.
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
Documentaries, videos and podcasts
DiA Imaging Analysis